WebLoren Miller is a Vice President, Clinical Operations at TaiwanJ Pharmaceuticals based in Lagrange, Georgia. Previously, Loren was a Vice Presiden t, Scientific & Regulatory Affairs at PPD and also held positions at GlaxoSmithKline. Loren received a Ph. D. degree from University of Kentucky. WebTaiwanJ Pharmaceuticals has signed a $26 million contract with Newsoara Biopharma to license out its drug candidate JKB-122 for further development in Asia. Image: TaiwanJ …

china biopharm partnering forum

WebTaiwanJ Pharmaceuticals Co Ltd Original Assignee Jenken Biosciences Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2002-10-22 Filing date 2003-10-22 Publication date 2012-03-20 Web24 Oct 2024 · TaiwanJ Pharmaceuticals Co., Ltd is a specialty pharmaceutical company dedicated to the development and commercialization of small molecules for unmet medical needs such as NAFLD/NASH,... instinx

TaiwanJ Pharmaceuticals reports positive data from …

Web22 Jan 2024 · TaiwanJ Pharmaceuticals has reported positive results from Phase II clinical trial evaluating the efficacy and safety of JKB-122 for the … WebTaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of … Web9 Mar 2024 · HSINCHU, Taiwan I March 8, 2024 I TaiwanJ Pharmaceuticals has signed a US$26 million contract with Newsoara Biopharma to license out its drug candidate JKB-122 for further development in Asia. On March 2 nd, 2024, TaiwanJ announced that its JKB-122, an effective phase 2 nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis … instinto reptiliano